Lumosa Therapeutics Co Ltd Sustainability Reports
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company focused on the development of novel therapies for neurological, oncological, and inflammatory diseases. The company's pipeline includes treatments for acute ischemic stroke and post-operative pain management.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG009KDN2Q1
6 reports from 2021 to 2025
